申请人:Blaquiere Nicole
公开号:US20120244149A1
公开(公告)日:2012-09-27
Benzoxazepin compounds of Formula I, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: Z
1
is CR
1
or N; Z
2
is CR
2
or N; Z
3
is CR
3
or N; Z
4
is CR
4
or N; and B is a pyrazolyl, imidazolyl, or triazolyl ring fused to the benzoxepin ring, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.
公式I中的苯并噁唑化合物,包括立体异构体、几何异构体、互变异构体、溶剂化物、代谢物和其药学上可接受的盐,其中:Z1是CR1或N;Z2是CR2或N;Z3是CR3或N;Z4是CR4或N;B是咪唑环、咪唑啉环或三唑环融合到苯并噁唑环上,可用于抑制脂质激酶,包括p110 alpha和其他PI3K同工酶,并用于治疗由脂质激酶介导的癌症等疾病。揭示了使用公式I中的化合物进行哺乳动物细胞中的体外、体内诊断、预防或治疗此类疾病或相关病理条件的方法。